Production (Stage)
Repligen Corporation
RGEN
$121.18
-$1.36-1.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.88% | 0.33% | -2.91% | -12.95% | -18.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.88% | 0.33% | -2.91% | -12.95% | -18.45% |
| Cost of Revenue | 0.07% | -2.40% | -7.43% | -6.90% | -8.05% |
| Gross Profit | 9.93% | 3.19% | 1.82% | -18.43% | -27.11% |
| SG&A Expenses | 11.40% | 9.86% | 20.96% | 12.10% | 1.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.78% | 2.36% | 2.98% | 0.21% | -4.34% |
| Operating Income | 6.37% | -23.69% | -58.75% | -79.04% | -74.31% |
| Income Before Tax | -154.45% | -147.67% | -87.54% | -81.96% | -76.59% |
| Income Tax Expenses | -98.94% | -107.20% | 205.30% | -16.13% | -25.14% |
| Earnings from Continuing Operations | -197.56% | -171.68% | -108.03% | -92.37% | -84.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -197.56% | -171.68% | -108.03% | -92.37% | -84.74% |
| EBIT | 6.37% | -23.69% | -58.75% | -79.04% | -74.31% |
| EBITDA | 7.29% | -5.95% | -24.11% | -48.00% | -49.19% |
| EPS Basic | -196.86% | -171.04% | -108.01% | -92.39% | -84.78% |
| Normalized Basic EPS | -9.60% | -36.27% | -51.90% | -69.06% | -63.52% |
| EPS Diluted | -201.69% | -173.93% | -108.31% | -92.47% | -84.73% |
| Normalized Diluted EPS | -8.92% | -35.53% | -50.89% | -68.34% | -62.92% |
| Average Basic Shares Outstanding | 0.45% | 0.39% | 0.40% | 0.41% | 0.45% |
| Average Diluted Shares Outstanding | -0.48% | -0.72% | -1.39% | -1.14% | -0.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |